Rubella Treatment Market - Top Companies and Manufacturers

Companies Dominating the Rubella Treatment Landscape

Bayer AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Novartis AG
Pfizer Inc.
Johnson & Johnson Services, Inc.
GlaxoSmithKline PLC
Reckitt Benckiser Group plc
Endo International plc
Bristol-Myers Squibb Company
Eli Lilly and Company
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.

Browse Key Market Insights with Data Illustration:

Rubella Treatment Market Size & Share, Growth Forecasts 2036

In the News

August 2021- GlaxoSmithKline announced that it has submitted a license application to the U.S Food and Drug Administration for PRIORIX, which is targeted for immunization against measles, mumps and rubella (MMR).
July 2019- Measles outbreak in the United States helped in boosting the sales of Merck’s vaccine by 58 percent in the second quarter of the year.

Frequently Asked Questions (FAQ)

Rubella Treatment Market size is projected to witness around 6.4% CAGR during the forecast period i.e., between 2024-2036.

The market growth is driven by growing incidences of rubella worldwide, and government initiatives about research and development of sophisticated diagnostic techniques.

North America industry is estimated to hold largest revenue share by 2036, on account of growing levels of awareness about rubella, high healthcare spending, and rising number of drug manufacturing facilities in the region.

The major players in the market are Novartis AG, Pfizer Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline PLC, and others.

Rubella Treatment Market - Top Companies and Manufacturers

Companies Dominating the Rubella Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the rubella treatment market worth?

Why is the demand for rubella treatment growing?

Which region dominated the majority of rubella treatment industry share?

Who are the top rubella treatment companies?